From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders.

Abstract excerpt

The field of primary immunodeficiency diseases (PID) is rapidly expanding with more than 300 genetically defined disorders that have been clinically described and molecularly analyzed. The molecular dissection of these entities has led to the discovery of new immunologic pathways and to novel and effective disease-specific therapies. This review provides a summary of these primary immune defects categorized by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmunity
• Share to Biomarkers
• Share to Disease Management